Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Taysha Gene Therapies (TSHA)

Annual Return

Over the past 3 years, TSHA has had an average annual return of +91.71%, outperforming the benchmark SPY, which returned +22.45% annual.

Over the past 5 years, TSHA has had an average annual return of -24.33%, underperforming the benchmark SPY, which returned +13.88% annual.

Since Sep 24, 2020, TSHA has had an average annual return of -22.71%, underperforming the benchmark SPY, which returned +17.59% annual.

2026202520242023202220212020
+0.92%+217.94%-2.31%-21.62%-80.61%-56.11%+10.31%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026-18.02%+0.48%-1.33%+42.95%-8.13%-5.45%+0.92%
2025-13.35%+6.74%-13.08%+39.45%+39.70%-14.74%+18.23%+6.96%+11.94%+51.73%-4.46%+16.04%+217.94%
2024-14.13%+107.75%-9.14%-15.34%+41.19%-34.71%-1.29%+1.31%-10.31%-15.93%+91.88%-46.62%-2.31%
2023-27.37%-38.42%-20.95%-3.01%-9.94%-5.17%+1.82%+375%-1.28%-25.89%-24.77%+0.55%-21.62%
2022-31.76%-19.85%+2.34%-43.87%-30.31%+45.85%+9.44%-22.40%-38.92%-10.85%+28.53%+2.18%-80.61%
2021-2.04%-1.57%-20.68%+27.14%-12.82%-5.78%-18.44%+14.99%-6.34%-16.01%-17.00%-10.25%-56.11%
2020-6.90%-7.14%+8.74%+17.34%+10.31%

Drawdown analysis of Taysha Gene Therapies (TSHA)

The maximum drawdown for the TSHA was -98.14%, occurring on Jun 28, 2023. This drawdown has not yet recovered.

The current TSHA drawdown is -82.52%.

Since Sep 24, 2020 TSHA has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 2 times
  • 10% or more: 3 times
DepthStartTo BottomBottomTo RecoverEndTotal
-98.14%Jan 20, 2021613Jun 28, 2023OngoingOngoingOngoing
-21.78%Sep 25, 202050Dec 7, 202012Dec 23, 202062
-10.74%Dec 23, 20208Jan 6, 20216Jan 14, 202114